Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

OmniAb, Inc. (OABI) Balance Sheet

As of 2026-06-30 (10-Q), OmniAb, Inc. (OABI) reported total assets of $290.3M, total liabilities of $30.0M and shareholders' equity of $260.3M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $24.3M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OABIOmniAb, Inc.Follow OABI — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
677.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 6 days
LineFY2021
Dec 21
FY2022
Nov 22
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.098.133.416.427.625.524.3
Short-term investments0.0—54.970.631.828.527.7
Receivables21.10.030.33.85.37.410.3
Inventory————0.00.81.0
Current assets22.5100.3125.094.968.165.366.0
Total assets304.5393.1421.2375.2325.6300.9290.3
Current liabilities20.612.326.023.115.116.313.8
Total liabilities70.267.179.860.637.933.930.0
Shareholders' equity234.3—341.4314.6287.6267.0260.3

USD millions · SEC XBRL

OmniAb, Inc. — questions

How much cash does OmniAb, Inc. have?
$24.3M in cash and cash equivalents as of 2026-06-30.
What are OmniAb, Inc.'s total assets?
$290.3M as of 2026-06-30.
What is OmniAb, Inc.'s shareholders' equity?
$260.3M as of 2026-06-30.

Every figure on this page comes from OmniAb, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.